- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Statin discontinuation in persons with and without Alzheimer’s disease ; volume:78 ; number:7 ; day:21 ; month:4 ; year:2022 ; pages:1145-1153 ; date:7.2022
European journal of clinical pharmacology ; 78, Heft 7 (21.4.2022), 1145-1153, 7.2022
- Urheber
-
Vu, Mai
Kettunen, Raimo
Tolppanen, Anna-Maija
Hartikainen, Sirpa
Taipale, Heidi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-022-03320-3
- URN
-
urn:nbn:de:101:1-2022080606582329357330
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vu, Mai
- Kettunen, Raimo
- Tolppanen, Anna-Maija
- Hartikainen, Sirpa
- Taipale, Heidi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial
Alzheimer’s Disease
Alzheimer's disease
Treatments in Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Genetics of Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer’s disease and immunotherapy
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial
Alzheimer’s Disease
Alzheimer's disease
Treatments in Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Genetics of Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer’s disease and immunotherapy
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial
Alzheimer’s Disease
Alzheimer's disease
Treatments in Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Genetics of Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer’s disease and immunotherapy
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease